SITC connectED is the new adaptive learning portal connecting users to online educational activities about cancer immunotherapy with opportunities for continuing education credits. Start with Introduction to Immunology lead by Christian Capitini, MD (University of Wisconsin).
Visit the SITC 2017 Annual Meeting website for the latest information on the premier destination for scientific exchange, education and networking in the cancer immunotherapy field.
SITC members who purchase Cancer Immunotherapy Principles and Practice receive a 20 percent discount and free shipping with a promo code.*
*Available only when ordering from Demos Medical Publishing
Support the Society for Immunotherapy of Cancer and the cancer immunotherapy field in general during Cancer Immunotherapy Month. Click here to learn all of the ways you can expand your knowledge base and help progress the field forward.
Non-Small Cell Lung Cancer Immunotherapy: Clinical Management
Complete this FREE online CME/CNE activity to learn more about immunotherapy for non-small cell lung cancer, then engage your patients in discussion today!
*Current as of August 2016
Learn basic immunology principles, the mechanisms and clinical applications of immunotherapy for disease states with FDA-approved treatments and much more. Register on-site on June 29 in Los Angeles for our Advances in Cancer Immunotherapy™ program, SITC's regional cancer immunotherapy education series.
Learn and share information in the new SITC Cancer Immunotherapy CONNECT Open Forum! Follow a few easy steps to create a free SITC CONNECT account, upload a profile photo and join the conversation.
Explore resources and educational opportunities for cancer
patients and those who advocate for them.
Track the latest advancements and educational opportunities in
cancer immunotherapy and immunology.
Advance science, submit your
manuscript and monitor the global progress of cancer immunotherapy research.
We have a patient with multiple brain metastases from melanoma beginning to develop symptoms (mental slowing and right facial droop) as we try to get him precerted for checkpoint inhibitor therapy. Any thoughts/anecdotes/data about how much if any ...
Did you know there are more than 800 resources available to SITC members? Access by your user type ( researcher , clinician , patient ) or by using the SITC Cancer Immunotherapy CONNECT Search (top right) to find exactly what you're looking ...
In light of what can occur in the TME in the steady state, malignant cells killed by intrinsic/extrincic stress factors in it can lead to danger-associated molecular patterns (e.g. HMGB-1) and plasma membrane exposure of the endoplasmic reticulum (ER) ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org